Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial of Belimumab in Early Lupus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03543839
Recruitment Status : Not yet recruiting
First Posted : June 1, 2018
Last Update Posted : May 23, 2019
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Cynthia Aranow, MD, Northwell Health

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Not yet recruiting
  Estimated Primary Completion Date : November 2022
  Estimated Study Completion Date : January 2023